INVE Technologies, Inc.
For the period ended Dec 31, 2024. Filed Mar 17, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 17, 2025
INVE$2.66+0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
(In thousands)
| Year Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows used in operating activities: | ||
| Net income (loss) | $74,820 | $(5,489) |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||
| Depreciation and amortization | 2,870 | 2,732 |
| Gain on sale of discontinued operations, net of taxes | (103,509) | — |
| Gain on investment | — | (132) |
| Loss on disposal of property and equipment | 98 | — |
| Write down of inventory | 807 | — |
| Amortization of debt issuance costs | 113 | 43 |
| Stock-based compensation expense | 8,730 | 3,971 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 6,158 | 2,890 |
| Inventories | 4,482 | 219 |
| Prepaid expenses and other assets | (2,613) | (361) |
| Accounts payable | (5,318) | (2,530) |
| Deferred revenue | 311 | 613 |
| Accrued income taxes payable | (2,017) | 182 |
| Accrued expenses and other liabilities | (365) | (981) |
| Net cash provided by (used in) operating activities | (15,433) | 1,157 |
| Cash flows from investing activities: | ||
| Capital expenditures | (1,493) | (4,284) |
| Proceeds from sale of discontinued operations, net of cash sold | 142,986 | — |
| Proceeds from investment | — | 132 |
| Net cash provided by (used in) investing activities | 141,493 | (4,152) |
| Cash flows from financing activities: | ||
| Borrowings under revolving loan facility, net of issuance costs | 9,887 | 23,906 |
| Repayments under revolving loan facility | (20,000) | (14,000) |
| Taxes paid related to net share settlement of restricted stock units | (1,642) | (796) |
| Repurchases of common stock | (1,879) | — |
| Proceeds from exercise of warrants | — | 963 |
| Net cash provided by (used in) financing activities | (13,634) | 10,073 |
| Effect of exchange rates on cash, cash equivalents, and restricted cash | (864) | 169 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 111,562 | 7,247 |
| Cash, cash equivalents and restricted cash | ||
| Beginning of period | 24,384 | 17,137 |
| End of period | $135,946 | $24,384 |
| Supplemental Disclosures of Cash Flow Information: | ||
| Interest paid | $324 | $451 |
| Taxes paid, net | $4,181 | $123 |
| Non-cash investing and financing activities: | ||
| Dividends earned on Series B preferred stock | $883 | $1,266 |
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | $560 | $2,368 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.